NxStage Medical (NXTM) Tops Q4 EPS by 2c

February 26, 2015 9:36 AM EST

NxStage Medical (NASDAQ: NXTM) reported Q4 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $79.9 million versus the consensus estimate of $75.75 million.

For earnings history and earnings-related data on NxStage Medical (NXTM) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings